Thumbnails similares a Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD

20 vecinos (thumb_512) · 88 views · HCPLive · Estados Unidos


★	Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD	HCPLive @hcplivenews	88	Estados Unidos
6	Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D	HCPLive @hcplivenews	1.6K	Estados Unidos	69
19	Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment	HCPLive @hcplivenews	374	Estados Unidos	66
10	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss	HCPLive @hcplivenews	250	Estados Unidos	68
12	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	67
18	Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD	HCPLive @hcplivenews	196	Estados Unidos	66
8	Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD	HCPLive @hcplivenews	152	Estados Unidos	69
3	FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD	HCPLive @hcplivenews	131	Estados Unidos	70
20	Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes \| ATS 2026	HCPLive @hcplivenews	117	Estados Unidos	66
16	How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD	HCPLive @hcplivenews	109	Estados Unidos	67
15	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	67
4	VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes	HCPLive @hcplivenews	96	Estados Unidos	70
9	ZUPREME-1: Petrelintide Reduces Obesity, Maintains Tolerability in Phase 2 Trial	HCPLive @hcplivenews	81	Estados Unidos	68
2	SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma	HCPLive @hcplivenews	78	Estados Unidos	71
11	Omalizumab vs Oral Immunotherapy for Multifood Allergy	HCPLive @hcplivenews	65	Estados Unidos	68
17	ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis	HCPLive @hcplivenews	58	Estados Unidos	66
1	Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment	HCPLive @hcplivenews	46	Estados Unidos	75
14	Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH	HCPLive @hcplivenews	46	Estados Unidos	67
13	What is the Link Between Atopic Dermatitis and Asthma? With Eingun James Song, MD	HCPLive @hcplivenews	40	Estados Unidos	67
7	Diagnosing Non-IgE Food Hypersensitivity \| Brian Lacy, MD, PhD \| EAC 2026	HCPLive @hcplivenews	31	Estados Unidos	69
5	Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D	HCPLive @hcplivenews	16	Estados Unidos	70